Listed

Stepan Co: Form 10-Q for the period ended Mar 31, 2014

Filed with the SEC on Apr 30, 2014 and accepted by EDGAR at Apr 30, 2014, 14:00 ET.

Share

Management's discussion and analysis

As filed, 41,570 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.

The matters discussed in the following discussion and analysis include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.

Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.

Overview

The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:

  • Surfactants – Surfactants, which accounted for 70 percent of consolidated net sales in the first quarter of 2014, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and two Asian sites (Philippines and Singapore). The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields (enhanced oil recovery or EOR). The joint venture is accounted for under the equity method, and its financial results are excluded from surfactant segment operating results. Sales and related profits of the Company’s surfactants to enhanced oil recovery customers are included in surfactants segment results.
  • Polymers – Polymers, which accounted for 25 percent of consolidated net sales in the first quarter of 2014, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively CASE products) and flexible foams. Polyester resins, which include liquid and powdered resins, are used in CASE and polyurethane systems house applications. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride

internally in the production of polyols. In the U.S., polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and polyester resins are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. In Asia, polyols are currently toll produced for the Company’s 80-percent owned joint venture in Nanjing, China.

  • Specialty Products – Specialty products, which accounted for 5 percent of consolidated net sales in the first quarter of 2014, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.

Deferred Compensation Plans

The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:

(In millions)

Income (Expense) For the Three Months Ended March 31 2014 2013 Change
Deferred Compensation (Administrative expense) $0.2 ($ 4.9) $5.1 (1)
Realized/Unrealized Gains on Investments (Other, net) — 0.8 (0.8)
Investment Income (Other, net) 0.2 0.1 0.1
Pretax Income Effect $0.4 ($ 4.0) $4.4

(1) See the Corporate Expenses section of this management’s discussion and analysis for details regarding the quarter-over-quarter change in deferred compensation expense.

Effects of Foreign Currency Translation

The Company’s foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the quarter-over-quarter changes in consolidated net sales and various income line items between the quarters ended March 31, 2014 and 2013:

(In millions)

Three Months Ended March 31 2014 2013 Increase (Decrease) (Decrease) Due to Foreign Translation
Net Sales $477.4 $456.5 $20.9 ($ 1.7)
Gross Profit 63.0 72.7 (9.7) (0.4)
Operating Income 22.5 28.3 (5.8) (0.3)
Pretax Income 18.1 25.3 (7.2) —

RESULTS OF OPERATIONS

Three Months Ended March 31, 2014 and 2013

Summary

Net income attributable to the Company for the first quarter of 2014 declined 32 percent quarter-over-quarter to $13.0 million, or $0.57 per diluted share, compared to $19.0 million, or $0.83 per diluted share, for the first quarter of 2013. The current quarter’s financial results were negatively impacted by the effects of protracted severe winter weather in the U.S. that led to higher maintenance, utility and transportation costs and to some lost sales volume due to Company and customer plant disruptions. Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first quarter of 2014 follows the summary.

Consolidated net sales increased $20.9 million, or five percent, quarter over quarter. Higher average selling prices favorably affected the net sales change by $33.2 million. A two percent decline in sales volume and the effects of foreign currency translation offset the average selling price impact by $10.6 million and $1.7 million, respectively. The increase in average selling prices was partially attributable to higher quarter-over-quarter raw material costs for surfactants. The polymers segment accounted for the consolidated sales volume improvement. The acquired Bayer MaterialScience LLC (BMS) North American polyester resins business (purchased in the second quarter of 2013) and strong quarter-over-quarter growth for European operations drove the polymer increase. Surfactants sales volume declined six percent due to reduced quarter-over-quarter volumes for North American operations resulting from lower biodiesel sales and the effects of prolonged extreme winter weather. Sales volumes for the specialty products segment declined nine percent due to a decrease in sales volume for food and flavoring products partially offset by an increase in sales volume for nutritional supplement and pharmaceutical products.

Operating income for the first quarter of 2014 declined $5.8 million, or 20 percent, from operating income reported for the last year’s first quarter. Gross profit fell $9.7 million, or 13 percent, largely due to lower profits for surfactants caused by higher manufacturing and transportation expenses and lower sales volume for operations in North America. The effect of the previously noted higher surfactants raw material costs was more than offset by selling price increases.

Operating expenses declined $3.9 million, or nine percent, between quarters. Deferred compensation expense accounted for $5.1 million of the decrease. The following summarizes the quarter-over-quarter changes in the individual income statement line items that comprise the Company’s operating expenses:

  • Administrative expenses declined $4.9 million, or 25 percent, quarter over quarter due to a $5.1 million reduction in deferred compensation expense. A first quarter 2014 decrease in the value of Company stock compared to a first quarter 2013 increase in the value of Company common stock caused the decline. See the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details.
  • Selling expenses increased $0.4 million, or three percent, quarter over quarter. The increase was mainly attributable to a $0.5 million increase in bad debt provision for a Latin American customer that moved into bankruptcy.
  • Research, development and technical service expenses (R&D) were up $0.6 million, or five percent, quarter over quarter. The increase in R&D expenses reflected higher expenses for salaries and outside testing services for North American operations partially offset by lower product registration expenses in Europe.

Net interest expense for the first quarter of 2014 increased $0.8 million, or 36 percent, over net interest expense for the first quarter of 2013. The increase reflected higher quarter-over-quarter average debt levels arising from a $100.0 million private placement note purchase agreement the Company executed in the second quarter of 2013. The Company borrowed the funds to finance the second quarter 2013 BMS North American polyester resins acquisition, other capital expenditures and general corporate purposes.

Other, net was less than $0.1 million of expense for the first quarter of 2014 compared to $0.6 million of income for the same period of 2013. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets was $0.2 million in the first quarter of 2014 compared to $1.0 million in last year’s first quarter. Foreign exchange losses totaled $0.2 million for the first quarter of 2014 compared to $0.4 million for the first quarter of 2013.

The effective tax rate was 28.1 percent for the first quarter of 2014 compared to 24.8 percent for the first quarter of 2013. The increase was primarily attributable to the expiration of the U.S. research and development tax credit and the small agri-biodiesel producer tax credit which were retroactively extended from January 1, 2012 through December 31, 2013 in January 2013. The Company recorded a tax benefit of $1.4 million in the first quarter of 2013 for amounts generated in 2012 and a tax benefit of $0.4 million for amounts generated in 2013. This increase was partially offset by a greater percentage of consolidated income being generated outside the U.S. where the effective tax rates are generally lower.

Segment Results

(In thousands)

For the three months ended March 31, 2014 Surfactants Polymers Specialty Products Segment Results Corporate Total
Net sales $335,710 $119,107 $22,625 $477,442 — $477,442
Operating income 18,338 10,826 4,021 33,185 (10,662) 22,523
For the three months ended March 31, 2013
Net sales $339,973 $95,998 $20,575 $456,546 — $456,546
Operating income 29,652 10,764 2,832 43,248 (14,954) 28,294

Surfactants

Surfactants net sales for the first quarter of 2014 declined $4.3 million, or one percent, from net sales for the first quarter of 2013. A six percent drop in sales volume, largely due to lower biodiesel sales and to the impact of severe winter conditions, and the effects of foreign currency translation accounted for $22.1 million and $3.0 million, respectively, of the net sales decline. An increase in average selling prices favorably affected the net sales change by $20.8 million. A quarter-over-quarter comparison of net sales by region follows:

(In thousands)

For the Three Months Ended March 31, 2014 March 31, 2013 Increase (Decrease) Percent Change
North America $208,424 $211,462 $(3,038) -1
Europe 75,358 78,183 (2,825) -4
Latin America 38,707 38,202 505 +1
Asia 13,221 12,126 1,095 +9
Total Surfactants Segment $335,710 $339,973 $(4,263) -1

Net sales for North American operations declined one percent due to a twelve percent decrease in sales volume and the unfavorable effects of foreign currency translation, which accounted for $24.5 million and $1.3 million, respectively, of the decline in net sales. Lower quarter-over-quarter biodiesel sales accounted for approximately 60 percent of the decline in North American sales volume. In 2013, the Company had some low-margin opportunistic biodiesel business that did not recur in 2014. Decreased sales of products used in laundry and cleaning and personal care applications contributed to the North American sales volume decline. The decline in laundry and cleaning and personal care sales volume was partially attributable to the severe winter weather that caused production issues at the Company’s and customers’ manufacturing facilities. Lost business due to the closure of a customer’s plant also contributed to the lower sales volume for laundry and cleaning and personal care products. Average selling prices increased twelve percent, which offset the effects of the sales volume decline and unfavorable foreign currency translation by $22.8 million. Higher quarter-over-quarter raw material costs led to the increase in average selling prices.

Net sales for European operations declined four percent due to a six percent decrease in sales volume and a three percent decrease in average selling prices, which accounted for $4.6 million and $1.9 million, respectively, of the quarter-over-quarter net sales decline. The favorable effects of foreign currency translation mitigated the decrease in net sales by $3.7 million. The decline in sales volume reflected lower demand for laundry and cleaning and personal care products as well as some lost business resulting from competitive pricing situations. Sales volumes for functional surfactants, primarily agricultural and emulsion polymers and foamers products, were up between quarters. Selling prices declined as a result of cost decreases for a number of major raw materials.

Net sales for Latin American operations increased one percent due to a 10 percent increase in sales volume and a three percent increase in average selling prices, which accounted for $3.7 million and $1.0 million, respectively, of the quarter-over-quarter net sales change. The effects of foreign currency translation negatively affected the change in net sales by $4.2 million. All Latin American locations posted quarter-over-quarter sales volume increases, with most of the improvement occurring in Brazil where the Company continues its strong emphasis on growth. The foreign currency translation effect resulted from the quarter-over-quarter weakening of the Brazilian real and Colombian and Mexican pesos against the U.S. dollar.

Net sales for Asian operations increased nine percent due to a seven percent increase in sales volume and increased average selling prices partially offset by $1.2 million of unfavorable foreign currency translation effect. The sales volume improvement was attributable to new business for the Singapore location.

Surfactants operating income for the first quarter of 2014 declined $11.3 million, or 38 percent, from operating income for the first quarter of 2013. Gross profit decreased $10.8 million principally due to lower sales volume and higher expenses in North America largely as a result of severe and prolonged winter conditions. The effect of higher average surfactants raw material costs was more than offset by selling price increases. Foreign currency translation contributed $0.6 million to the gross profit decline. Operating expenses increased $0.5 million, or two percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended March 31, 2014 March 31, 2013 Increase (Decrease) Percent Change
North America $24,973 $39,474 $(14,501) -37
Europe 7,336 6,869 467 +7
Latin America 5,303 5,492 (189) -3
Asia 3,196 (187) 3,383 NM
Surfactants Segment Gross Profit $40,808 $51,648 $(10,840) -21
Operating Expenses 22,470 21,996 474 +2
Operating Income $18,338 $29,652 $(11,314) -38

North American gross profit declined 37 percent quarter over quarter due to lower sales volume and higher expenses. Manufacturing costs were up $4.1 million, or 13 percent, quarter over quarter largely due to increased maintenance and utility costs caused by prolonged inclement winter weather. The Company also incurred additional transportation expenses due to the transfer of some production in weather-affected locations to other less impacted North American plants. Unrelated to the weather, the Company’s Canadian plant recognized $0.9 million of accelerated depreciation related to the restructuring plan approved in the fourth quarter of 2013.

Gross profit for European operations increased seven percent quarter over quarter. Lower raw material costs, a more favorable mix of sales and a $0.3 million favorable foreign currency translation effect more than offset the impact of a six percent decline in sales volume.

Gross profit for Latin American operations declined three percent despite the 10 percent improvement in sales volume. An unfavorable $0.8 million foreign currency translation impact more than offset the effect of the higher sales volume.

The quarter-over-quarter increase in gross profit for Asian operations was driven by increased sales volume for Singapore. Commercial operations at the Singapore plant were just underway in the year-ago quarter.

Operating expenses for the surfactants segment were up $0.5 million, or two percent, quarter over quarter. The expense increase was mainly attributable to an increase in bad debt provision for a Latin American customer that moved into bankruptcy. The effects of foreign currency translation reduced the operating expense increase by $0.2 million.

Polymers

Polymers net sales for the first quarter of 2014 increased $23.1 million, or 24 percent, over net sales for the first quarter of 2013. A 20 percent increase in sales volume, higher average selling prices and the effects of foreign currency translation accounted for $19.6 million, $2.4 million and $1.1 million, respectively, of the quarter-over-quarter net sales improvement. The increase in sales volume was attributable to the acquired BMS North American polyester resins business (purchased in the second quarter of 2013) and to solid growth for European operations. A quarter-over-quarter comparison of net sales by region follows:

(In thousands)

For the Three Months Ended March 31, 2014 March 31, 2013 Increase Percent Change
North America $73,685 $60,059 $13,626 +23
Europe 41,676 33,050 8,626 +26
Asia and Other 3,746 2,889 857 +30
Total Polymers Segment $119,107 $95,998 $23,109 +24

Net sales for North American operations increased 23 percent primarily due to the effects of the acquired BMS North American polyester resins business (purchased in the second quarter of 2013). The acquired business accounted for $17.5 million of the quarter-over-quarter net sales increase. Without the acquired polyester resins business, net sales declined $3.9 million, or seven percent, due to a four percent decrease in average selling prices (reflecting lower average raw material costs) and a two percent decrease in sales volume. Sales volumes for polyols used in rigid foam applications improved five percent. Phthalic anhydride sales volume declined 10 percent due to lost sales at a large customer.

Net sales for European operations increased 26 percent due to a 29 percent increase in sales volume and to the effects of foreign currency translation, which accounted for $9.6 million and $1.2 million, respectively, of the net sales improvement. Local regulations aimed at increasing energy conservation and heightened interest in energy-efficient insulation materials continued to create strong demand for the Company’s polyol products used in rigid insulation board and metal panels. Average selling prices declined five percent, which tempered the quarter-over-quarter net sales improvement by $2.2 million.

Net sales for Asia and Other operations increased 30 percent quarter over quarter due to an 11 percent increase in sales volume and higher average selling prices. The Company is currently supplying customers in China and other parts of Asia with product imported from other Company sites and from local manufacturers. This sourcing is expected to continue until a new plant in China is constructed.

Polymer operating income for the first quarter of 2014 increased $0.1 million, or one percent, over operating income for the first quarter of 2013. Gross profit increased $0.7 million quarter-over-quarter, due to a 20 percent increase in sales volume partially offset by the effects of reduced sales margins. Operating expenses increased $0.7 million, or 11 percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:

(In thousands)

Gross Profit For the Three Months Ended March 31, 2014 March 31, 2013 Increase Percent Change
North America $11,434 $11,411 $23 —
Europe 5,521 5,137 384 +7
Asia and Other 310 3 307 NM
Polymers Segment Gross Profit $17,265 $16,551 $714 +4
Operating Expenses 6,439 5,787 652 +11
Operating Income $10,826 $10,764 $62 +1

31

Gross profit for North American operations increased less than one percent despite the positive contributions of the acquired BMS North American polyester resins business and the sales volume improvement for polyols used in rigid foam applications. Sales of phthalic anhydride contributed $2.2 million less to profit in the first quarter of 2014 than in the first quarter of 2013 due to lower sales volume, higher manufacturing expenses and a less favorable inventory position for orthoxylene (raw material for phthalic anhydride). Phthalic anhydride manufacturing costs were 17 percent higher quarter over quarter due to increased maintenance and utility costs caused by extended severe winter conditions.

Gross profit for European operations increased seven percent due to the increase in sales volume. Selling price reductions and higher manufacturing expenses partially offset the effect of the improved sales volume. Current quarter manufacturing expenses were higher than last year’s quarter partially due to favorable nonrecurring adjustments made in 2013.

The increase in gross profit for Asia and Other operations was due to the increase in sales volume and to a more favorable mix of sales.

Operating expenses for the polymers segment were up $0.7 million, or 11 percent, quarter over quarter. The increase reflected additional expenses to support the BMS North American polyester resins business (purchased in the second quarter of 2013). The effects of foreign currency translation contributed $0.1 million to the increase.

Specialty Products

Net sales for the first quarter of 2014 increased $2.1 million, or 10 percent, over net sales for the first quarter of 2013 despite a nine percent decrease in sales volume. Lower quarter-over-quarter sales of products used in food and flavoring applications partially offset by higher sales volumes for products used in nutritional supplement and pharmaceutical applications accounted for the sales volume decline. Selling price increases coupled with a more favorable sales mix more than offset the effect of the sales volume decline. Operating income increased $1.2 million, or 42 percent, quarter over quarter due to higher selling prices and a more profitable mix of sales.

Corporate Expenses

Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, declined $4.3 million to $10.7 million for the first quarter of 2014 from $15.0 million for the same quarter of 2013. The quarter-over-quarter decline in corporate expenses was attributable to a $5.1 million decrease in deferred compensation expense ($0.2 million of income for the first quarter of 2014 compared to $4.9 million of expense for the first quarter of 2013). A first quarter 2014 decrease ($1.07 per share) in the value of Company stock, to which a substantial portion of the deferred compensation obligation is tied, compared to a first quarter 2013 increase ($7.56 per share) in the value of Company common stock led to the quarter-over-quarter decline in deferred compensation expense. The following table presents the quarter end Company common stock market prices used in the computation of deferred compensation expense:

2014 3/31 2013 12/31 3/31 2012 12/31
Company Stock Price $64.56 $65.63 $63.10 $55.54

Higher patent fees to support the Company’s innovation growth endeavors and exploratory acquisition expenses partially offset the decrease in deferred compensation expense.

LIQUIDITY AND CAPITAL RESOURCES

For the three months ended March 31, 2014, operating activities were a cash use of $9.0 million versus a use of $9.9 million for the comparable period in 2013. For the current year period, investing cash outflows totaled $23.1 million and financing activities consumed $4.0 million. Overall, cash declined by $36.6 million in the first quarter of 2014, including a $0.5 million reduction attributable to foreign currency translation.

For the current year-to-date, net income was down by $6.0 million and working capital consumed $7.6 million less than for the comparable year-ago period. Cash outflows for investing activities were up by $0.2 million year over year. Cash flow for financing activities was a use of $4.0 million in 2014 compared to a source of $11.3 million in 2013.

For the current year-to-date, accounts receivable were a use of $30.0 million compared to a use of $31.8 million for the comparable period in 2013. Inventories were a use of $13.2 million in 2014 versus a use of $16.5 million in 2013. Accounts payable and accrued liabilities were a cash source of $6.3 million in 2014 compared to a source of $5.5 million for the same period in 2013.

Working capital requirements were lower during the first three months of 2014, compared to the same quarter in 2013 due to lower sales quantities, partially offset by rising raw material costs which drove higher average selling prices to customers. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Fluctuations in raw material costs translate directly to inventory carrying costs and indirectly to customer selling prices and accounts receivable.

The increase in accounts receivable since December 31, 2013, was driven approximately equally by the combination of higher quarterly sales volumes and higher selling prices, partially offset by improved accounts receivable turnover since year-end. Slightly more than half of the year-to-date inventory increase resulted from higher raw material costs with the remainder attributable to planned increases to support customer service levels. The Company has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2014.

Investing cash outflows for the current year-to-date included capital expenditures of $20.5 million compared to $21.0 million for the comparable period last year. Other investing activities consumed $2.6 million in 2014 versus $1.9 million in 2013.

For 2014, the Company estimates that capital expenditures will range from $100 million to $110 million including capacity expansions in Brazil, Germany, Singapore and the United States.

The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit when, in management’s opinion, the Company’s shares are undervalued in the market. For the first three months of 2014, the Company purchased 7,180 shares in the open market at a total cost of $0.4 million. At March 31, 2014, there were 951,132 shares remaining under the current share repurchase authorization.

As of March 31, 2014, the Company’s cash and cash equivalents totaled $96.7 million, including $29.7 million in two separate U.S. money market funds, each of which was rated AAA by Standard and Poor’s and Aaa by Moody’s. Cash in U.S. demand deposit accounts totaled $21.3 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $45.7 million at March 31, 2014.

Consolidated balance sheet debt decreased by $1.0 million for the current year-to-date, from $270.6 million to $269.6 million. Since last year-end, foreign debt decreased by $1.0 million and domestic debt was unchanged. Net debt (which is defined as total debt minus cash) increased by $35.6 million for the current year-to-date, from $137.3 million to $172.9 million. As of March 31, 2014, the ratio of total debt to total debt plus shareholders’ equity was 32.3 percent compared to 32.8 percent at December 31, 2013. As of March 31, 2014, the ratio of net debt to net debt plus shareholders’ equity was 23.5 percent compared to 19.9 percent at December 31, 2013.

At March 31, 2014, the Company’s debt included $242.1 million of unsecured private placement loans with maturities extending from 2014 through 2025. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.

The Company has a committed $125.0 million multi-currency syndicated revolving credit agreement. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. This unsecured facility is the Company’s primary source of short-term borrowings and is committed through September 20, 2017, with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of March 31, 2014, the Company had outstanding letters of credit of $3.0 million and no borrowings under this agreement, with $122.0 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.

Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At March 31, 2014, the Company’s European subsidiaries had bank term loans of $5.2 million with maturities through 2016 and short-term bank debt of $21.6 million with remaining short-term borrowing capacity of $15.1 million. The Company’s Latin American subsidiaries had no short-term bank debt with $16.3 million of unused short-term borrowing capacity. The Company’s Philippine subsidiary had $0.7 million of short-term bank loans, which were guaranteed by the Company, with $7.3 million of unused borrowing capacity. The Company’s majority-owned joint venture in China had no short-term bank debt, with unused borrowing capacity of $6.5 million, on bank credit lines guaranteed by the Company.

The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Quimica Ltda., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:

1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.

2. The Restricted Group must maintain net worth of at least $275.0 million.

3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.

4. The Restricted Group may pay dividends and purchase treasury shares after December 31, 2011, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2012. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 13, Debt, in the Notes to Consolidated Financial Statements.

The Company believes it was in compliance with all of its loan agreements as of March 31, 2014. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2014.

ENVIRONMENTAL AND LEGAL MATTERS

The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first three months of 2014 and 2013, the Company’s expenditures for capital projects related to the environment were $0.5 million and $1.5 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $4.7 million and $4.1 million for the three months ended March 31, 2014 and 2013, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.

Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $10.2 million to $29.0 million at March 31, 2014, compared to $9.7 million to $28.9 million at December 31, 2013. At March 31, 2014, and December 31, 2013, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $15.2 million and $14.7 million, respectively. During the first three months of 2014, cash outlays related to legal and environmental matters approximated $0.3 million compared to $0.6 million for the first three months of 2013.

For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.

OUTLOOK

Lower first quarter earnings were largely due to the adverse winter weather in North America and other issues which generally should not recur. In March and April the Company’s business seems back on track; however lower first quarter earnings will make it a challenge to exceed 2013 full year earnings from operations.

Despite this setback, the Company remains on track in delivering its strategic objectives. The Company continues to recognize earnings growth from the 2013 acquisition from BMS and previous capacity expansions in Brazil, Europe and Singapore. The Company’s balance sheet is healthy, and management will continue to pursue investments that will accelerate Company growth.

Surfactant earnings should improve as the year progresses driven by greater agricultural sales, continued consumer product growth in Brazil, projected demand for enhanced oil recovery surfactants as well as gains from operational efficiencies.

Polymers should continue grow. Improving economies in the U.S. and Europe, as well as the recent conversions of insulated metal panel and new C.A.S.E. customers, should contribute to full year organic earnings growth. The North American polyester resin business purchased from BMS is now fully integrated and is delivering the benefits previously projected.

CRITICAL ACCOUNTING POLICIES

There have been no changes to the critical accounting policies disclosed in the Company’s 2013 Annual Report on Form 10-K.

Controls and procedures

As filed, 729 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

a. Evaluation of Disclosure Controls and Procedures

Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of March 31, 2014.

b. Changes in Internal Control Over Financial Reporting

There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2014-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2014-01-01 to 2014-03-31$477.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2014-01-01 to 2014-03-31$414.4mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2014-01-01 to 2014-03-31$63.0mus-gaap:GrossProfit
Operating income3 months2014-01-01 to 2014-03-31$22.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2014-01-01 to 2014-03-31$3.0mus-gaap:InterestExpense
Income tax3 months2014-01-01 to 2014-03-31$5.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2014-01-01 to 2014-03-31$13.0mus-gaap:NetIncomeLoss
Diluted EPS3 months2014-01-01 to 2014-03-31$0.57us-gaap:EarningsPerShareDiluted
Basic EPS3 months2014-01-01 to 2014-03-31$0.57us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2014-01-01 to 2014-03-3122,964,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2014-01-01 to 2014-03-31−$9.0mus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Capital expenditure3 months2014-01-01 to 2014-03-31$20.5mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2014-01-01 to 2014-03-31$3.8mus-gaap:PaymentsOfDividends
Share repurchases3 months2014-01-01 to 2014-03-31$430.0kus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2014-03-31$96.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2014-03-31$613.5mus-gaap:AssetsCurrent
Total assetsAt period end2014-03-31$1.17bnus-gaap:Assets
Current liabilitiesAt period end2014-03-31$269.2mus-gaap:LiabilitiesCurrent
Long-term debtAt period end2014-03-31$234.6mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2014-03-31$35.1mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2014-03-31$562.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-14-171098. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.